association (references)

References for: association

Full identifier: http://purl.org/np/RAA6yBWbyBjegdp0jAohUmaheBFZ9JzzrOt_GqjO_Bbj8#association

Nanopublication	Part	Subject	Predicate	Object	Published By	Published On
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#type type	http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement	Leoni Bücken	2021-06-12T11:20:48.407Z
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/2000/01/rdf-schema#label label	enbrel is a tumor necrosis factor tnf blocker indicated for the treatment of rheumatoid arthritis ra 1 1 polyarticular juvenile idiopathic arthritis jia in patients aged 2 years or older 1 2 psoriatic arthritis psa 1 3 ankylosing spondylitis as 1 4 plaque psoriasis pso in patients 4 years or older 1 5 enbrel is indicated for reducing signs and symptoms inducing major clinical response inhibiting the progression of structural damage and improving physical function in patients with moderately to severely active rheumatoid arthritis ra enbrel can be initiated in combination with methotrexate mtx or used alone enbrel is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis jia in patients ages 2 and older enbrel is indicated for reducing signs and symptoms inhibiting the progression of structural damage of active arthritis and improving physical function in patients with psoriatic arthritis psa enbrel can be used with or without methotrexate enbrel is indicated for reducing signs and symptoms in patients with active ankylosing spondylitis as enbrel is indicated for the treatment of patients 4 years or older with chronic moderate to severe plaque psoriasis pso who are candidates for systemic therapy or phototherapy	Leoni Bücken	2021-06-12T11:20:48.407Z
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#object object	http://purl.obolibrary.org/obo/DOID_9008 DOID_9008	Leoni Bücken	2021-06-12T11:20:48.407Z
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate	https://w3id.org/biolink/vocab/treats treats	Leoni Bücken	2021-06-12T11:20:48.407Z
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject	https://identifiers.org/drugbank:DB00005 drugbank:DB00005	Leoni Bücken	2021-06-12T11:20:48.407Z
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/association_type association_type	https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation	Leoni Bücken	2021-06-12T11:20:48.407Z
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/provided_by provided_by	https://w3id.org/um/NeuroDKG NeuroDKG	Leoni Bücken	2021-06-12T11:20:48.407Z
http://purl.org/np/RAA6yBWbyB... RAA6yBWbyB	links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion	association	https://w3id.org/biolink/vocab/relation relation	https://w3id.org/um/neurodkg/SymptomaticReliefIndication SymptomaticReliefIndication	Leoni Bücken	2021-06-12T11:20:48.407Z